Functional single-cell hybridoma screening using droplet-based microfluidics

Abstract excerpt

Monoclonal antibodies can specifically bind or even inhibit drug targets and have hence become the fastest growing class of human therapeutics. Although they can be screened for binding affinities at very high throughput using systems such as phage display, screening for functional properties (e.g., the inhibition of a drug target) is much more challenging. Typically these screens require the generation of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Innovative Microfluidic and Catalytic Techniques Innovation
• Share to Monoclonal and Polyclonal Antibodies Research